Sign up
Quantellect · Congress · Trade Detail
NASDAQ: SRPTSarepta Therapeutics Inc
DemocratHouse

Gilbert Ray Cisneros, Jr. bought Sarepta Therapeutics Inc (NASDAQ: SRPT)

Gilbert Ray Cisneros, Jr. (D-CA), a U.S. Representative, has disclosed 9 trades in Sarepta Therapeutics Inc (SRPT) since 2019, 7 purchases and 2 sales, worth an estimated $72K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Gilbert Ray Cisneros, Jr. bought $1,001 - $15,000 of Sarepta Therapeutics Inc (NASDAQ: SRPT) on April 9, 2019. Since that trade, SRPT is down -87.47% against the S&P 500 up +181.85%, an outperformance of -269.32%.

Across these filings, Gilbert Ray Cisneros, Jr. has been a net buyer of SRPT (a buy-to-sell ratio of 3.50). The most recent disclosed SRPT transaction shown was dated April 14, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

SRPT trades
9
Disclosed Vol
$72K
Buys
7
78%
Sells
2
22%
Buy / Sell
3.50
ratio
First → Last
2019–2025

Gilbert Ray Cisneros, Jr.'s SRPT trades vs the price

SRPT is down -87.47% since Gilbert Ray Cisneros, Jr. bought on April 9, 2019, versus +181.85% for the S&P 500.

Performance since this trade

Price change since trade
-87.47%
S&P 500 change since trade
+181.85%
Outperformance vs S&P 500
-269.32%

All Gilbert Ray Cisneros, Jr. SRPT trades

TradedTypeSizeReturnEst. profit
April 14, 2025SELL$54.63-71.56%
September 14, 2020BUY$138.50-88.78%-$7K
June 10, 2020SELL$159.83-90.28%
October 11, 2019BUY$83.48-81.39%-$7K
October 10, 2019BUY$83.16-81.32%-$7K
April 9, 2019BUY$124.01-87.47%-$7K
March 11, 2019BUY$134.39-88.44%-$7K
February 27, 2019BUY$151.68-89.76%-$7K
February 26, 2019BUY$140.04-88.91%-$7K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Gilbert Ray Cisneros, Jr. & SRPT trading FAQ

Is it legal for Gilbert Ray Cisneros, Jr. to trade Sarepta Therapeutics Inc (SRPT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Sarepta Therapeutics Inc (SRPT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Gilbert Ray Cisneros, Jr. buy SRPT?

Gilbert Ray Cisneros, Jr. disclosed a purchase of $1,001 - $15,000 of Sarepta Therapeutics Inc (SRPT) on April 9, 2019, according to public STOCK Act filings.

How has SRPT performed since Gilbert Ray Cisneros, Jr.'s trade?

Since Gilbert Ray Cisneros, Jr. bought SRPT on April 9, 2019, the stock is down -87.47%, versus +181.85% for the S&P 500 over the same period, an outperformance of -269.32%.

How many times has Gilbert Ray Cisneros, Jr. traded SRPT?

Gilbert Ray Cisneros, Jr. has disclosed 9 SRPT trades since 2019 (7 purchases and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional SRPT trades?

Quantellect tracks every disclosed congressional trade in Sarepta Therapeutics Inc (SRPT) on the Sarepta Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.

Gilbert Ray Cisneros, Jr.'s SRPT tradesAll congressional filings for Sarepta Therapeutics IncGilbert Ray Cisneros, Jr.'s full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.